The use of palliative care in ovarian cancer resulted in a decrease in overall readmissions and index hospitalization costs.
Alex Francoeur, MD
Advertisement
Articles by Alex Francoeur, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
2
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
3
What is the Impact of the SHARON Trial on Pancreatic Cancer Research?
4
Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy
5
